Tests of a vaccine for SIV in monkeys found greater resistance to SIV in animals producing antibodies against this region.
•
In 1984, after the confirmation of the etiological agent of AIDS by scientists at the U.S. National Institutes of Health and the Pasteur Institute, the United States Health and Human Services Secretary Margaret Heckler declared that a vaccine would be available within two years.
HIV | HIV/AIDS | vaccine | MMR vaccine | Vaccine | HIV trial in Libya | DPT vaccine | Serum and Vaccine Institute in Al-A'amiriya | President's Commission on the HIV Epidemic | Polio vaccine | polio vaccine | International Vaccine Institute | HIV/AIDS in Africa | HIV-AIDS | Vel' d'Hiv Roundup | Vaccine Damage Payment | Tat (HIV) | Pneumococcal vaccine | Office of HIV/AIDS Network Coordination | National Childhood Vaccine Injury Act | Measuring an HIV patient's CD4 | International Vaccine Institute (IVI) | International HIV/AIDS Alliance | Inactivated vaccine | HIV Prevention Trials Network | Hib vaccine | Hepatitis B vaccine | hepatitis B vaccine | Desmond Tutu HIV Foundation | Criminal transmission of HIV |
AIDSVAX is an experimental HIV vaccine that was developed originally at Genentech in San Francisco, California, and later tested by the VaxGen company, a Genentech offshoot.